PSA Archives - Gross Overtreatment

FDA approves new type of PSA testing methodology

Posted on May 22, 2022September 26, 2022 by Info

In January 2019, the FDA approved the “finger-prick” Sangia Total PSA blood test developed by OPKO Diagnostics. It seems likely that many urology practices will be interested in using a method like this for PSA testing over the next couple of years, since it will mean (effectively) instant access to patients’ PSA data at the time of their regular visits...Read More

Rising PSA Leads To Too Many Unnecessary Prostate Biopsies

Posted on May 2, 2022September 26, 2022 by Info

If a male's PSA (prostate specific antigen) has risen rapidly in recent years, he should not have a biopsy if his clinical exam is normal and the total PSA level is not yet high, researchers from Memorial Sloan-Kettering Cancer Center wrote in the Journal of the National Cancer Institute. They added that PSA velocity is a poor predictor of prostate cancer and...Read More

What is the difference between PSA and free PSA?

Posted on April 22, 2022September 26, 2022 by Info

What is the difference between PSA and free PSA? Do I need to have both tests? Whether you need both tests really depends on your individual situation. That’s why this question generates so much debate and confusion. PSA, a protein produced by prostate gland cells, circulates through the body in two ways: either bound to other proteins or on...Read More

Is PSA Testing for Prostate Cancer Bad Health Advice?

Posted on April 22, 2022September 26, 2022 by Info

Is the PSA reliable enough as a screening test to pick out only those few men who have the potentially lethal type of prostate cancer? Many people are questioning the validity of the PSA and its use as a reliable screening test. So let’s discuss what is known about the PSA. The Prostatic Specific Antigen (PSA) In order for...Read More